Waters Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Udit Batra

Chief executive officer

US$8.7m

Total compensation

CEO salary percentage	12.6%
CEO tenure	3.6yrs
CEO ownership	n/a
Management average tenure	3.1yrs
Board average tenure	3.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Udit Batra's remuneration changed compared to Waters's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	US$9m	US$1m	US$642m
Sep 30 2023	n/a	n/a	US$653m
Jul 01 2023	n/a	n/a	US$675m
Apr 01 2023	n/a	n/a	US$689m
Dec 31 2022	US$9m	US$1m	US$708m
Oct 01 2022	n/a	n/a	US$697m
Jul 02 2022	n/a	n/a	US$702m
Apr 02 2022	n/a	n/a	US$705m
Dec 31 2021	US$9m	US$1m	US$693m
Oct 02 2021	n/a	n/a	US$695m
Jul 03 2021	n/a	n/a	US$660m
Apr 03 2021	n/a	n/a	US$616m
Dec 31 2020	US$6m	US$285k	US$522m

Compensation vs Market: Udit's total compensation ($USD8.74M) is above average for companies of similar size in the BR market ($USD5.98M).

Compensation vs Earnings: Udit's compensation has been consistent with company performance over the past year.

CEO

Udit Batra (52 yo)

3.6yrs

Tenure

US$8,742,180

Compensation

Dr. Udit Batra, PhD, has been the President, Chief Executive Officer and Director at Waters Corporation since September 1, 2020. Dr. Batra served as Chief Executive Officer of Life Science business of Merc...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Udit Batra	President	3.6yrs	US$8.74m	no data
Amol Chaubal	Senior VP & CFO	2.9yrs	US$2.66m	0% $ 0
Jianqing Bennett	Senior Vice President of TA Instruments Division & Waters Clinical Business Unit	2.9yrs	US$2.11m	0.0047% $ 4.4m
Christos Ross	Senior VP of Global Operations & Interim Senior VP of the Waters Division	1.8yrs	no data	no data
Caspar Tudor	Director of Investor Relations	no data	no data	no data
Keeley Aleman	Senior VP	4.5yrs	US$2.05m	0.0034% $ 3.2m
Kristen Garvey	Vice President of Corporate Communications	5.3yrs	no data	no data
Patrick Conway	Interim Vice President of Human Resources	less than a year	no data	no data
Daniel Rush	Senior Vice President of Strategy & Transformation	3.3yrs	no data	no data
John Lynch	Treasurer	no data	no data	no data

3.1yrs

Average Tenure

49yo

Average Age

Experienced Management: WATC34's management team is considered experienced (3.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Udit Batra	President	3.6yrs	US$8.74m	no data
Linda Baddour	Independent Director	5.6yrs	US$334.86k	0% $ 0
Christopher Kuebler	Independent Director	17.9yrs	US$328.86k	0% $ 0
Richard Fearon	Independent Director	1.1yrs	US$256.04k	0.0024% $ 2.3m
Mark Vergnano	Independent Director	1.4yrs	US$312.36k	0.0082% $ 7.7m
Daniel Brennan	Independent Director	1.4yrs	US$321.36k	0.0028% $ 2.7m
Pearl Huang	Independent Director	3.3yrs	US$322.14k	0.0024% $ 2.2m
Flemming Ornskov	Independent Chairman	6.8yrs	US$480.36k	0% $ 0
Wei Jiang	Independent Director	2.8yrs	US$307.86k	0.0019% $ 1.7m

3.3yrs

Average Tenure

65yo

Average Age

Experienced Board: WATC34's board of directors are considered experienced (3.3 years average tenure).

Waters Management

Management criteria checks 3/4

Key information

Recent management updates

Waters Corporation, Annual General Meeting, May 23, 2024

Waters Corporation Announces Resignation of Jonathan Pratt as Senior Vice President of the Waters Division

Waters Corporation Announces Executive Changes

Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors

Waters Corporation, Annual General Meeting, May 24, 2022

Waters Corporation Announces Resignation of John Ballbach from the Board of Directors

Recent updates

Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC Columns

Waters Corporation, Annual General Meeting, May 23, 2024

Waters Corporation Provides Earnings Guidance for the First Quarter and Full-Year 2024

Waters Corporation Announces Resignation of Jonathan Pratt as Senior Vice President of the Waters Division

Waters Corporation Launched OligoWorks SPE Workflow and Kits

Waters Corporation Introduces DynaPro™? ZetaStar™? Instrument from its Wyatt Technology™? Portfolio for Nanoparticle Analysis

Waters Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023

Waters Corporation Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications

Waters Corporation Boosts Resolution and Triples Scan Speed of Select Series MRT for Metabolomics and MS Imaging

Waters Corporation Provides Earnings Guidance for the Second Quarter of 2023 and Fiscal Year 2023

Waters Corporation Provides Earnings Guidance for the First Quarter of 2023 and Fiscal Year 2023

Waters Corporation Announces Waters_Connect™ System Monitoring

Waters Corporation Announces Executive Changes

Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors

Waters Introduces New PFAS Quantitation Workflow Enabled by Enhancements to Waters_Connect Informatics Platform

Waters Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot

Waters Extends Capabilities of Flagship Ta Instruments Rheometer for Efficient and Repeatable Powder Analysis

Waters Corporation Provides Earnings Guidance for the Third Quarter Ending October 1, 2022 and Full Year Ending December 31, 2022

Waters Corporation to Report Q2, 2022 Results on Aug 02, 2022

Waters Corporation(NYSE:WAT) dropped from Russell 1000 Value-Defensive Index

Waters Corporation Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development

Waters Corporation Provides Earnings Guidance for the Quarter Ending July 2, 2022 and Full Year Ending December 31, 2022

Waters Corporation, Annual General Meeting, May 24, 2022

Waters Corporation Announces Resignation of John Ballbach from the Board of Directors

Waters Introduces Xevo TQ Absolute

Waters Corporation Provides Earnings Guidance for the First Quarter Ending April 2, 2022 and Year Ending December 31, 2022

Waters Corporation Introduces the Waters™ BioAccord™ System

Waters Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2021

Waters Corporation Introduces TRIOS AutoPilot Software

Waters Corp. Introduces the Waters Arc Premier System

Waters Corporation Introduces the Sars-Cov-2 Lc-Ms Kit (Ruo) to Advance Clinical Research of Infectious Diseases

Waters Corporation Provides Earnings Guidance for the Three Months Ended July 3, 2021 and for the Full Year Ended December 31, 2021

Waters Corporation Introduces A New Peptide Multi-Attribute Method Workflow for the Waters BioAccord LC-MS System

Waters Corporation Improves Ease and Reliability of Small Molecule Analysis with ACQUITY RDa Detector

Waters and TetraScience Partner to Deliver New Levels of Data Access and Insights with Empower Data Science Link

Waters Corporation Introduces the OttoTM SPEcialist Positive Pressure Manifold

Waters Corporation's APGC-MS/MS System Accepted for Advanced Dioxin and Furan Analysis Following USEPA Approval of SGS AXYS Method 16130

Waters Corporation Appoints Pearl S. Huang to Board of Directors

Waters Corporation Announces CFO Changes

Megadalton Solutions, Inc. Announces Expansion of Collaboration with Waters Corporation

Waters Corporation Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact RADIAN ASAP System

Waters Corporation Introduces Acquity Premier Columns

Waters Corporation (NYSE: WAT) signed an agreement to acquire rheology instruments and services business of Rheometric Scientific, Inc. for $23 million.

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age